Use of Remdesivir in severe COVID-19 Pregnant Patient

JOURNAL TITLE: Research & Innovation in Anesthesia

Author
1. Saravanan Palavesam
2. Neeraj Kumar
3. Ajeet Kumar
4. Abhyuday Kumar
5. Chethan Vamshi
ISSN
DOI
10.5005/jp-journals-10049-2016
Volume
7
Issue
2
Publishing Year
2022
Pages
3
  • Article keywords
    COVID-19, High flow nasal cannula, Remdesivir, Third trimester

    Abstract

    The current coronavirus disease 2019 (COVID-19) pandemic has had a significant impact on our healthcare system. Still, very little is known about the treatment modalities in the context of severe COVID in pregnancy. We describe a case of a 28-year-old patient who presented with severe COVID-19 and was admitted to our intensive care unit (ICU) in her third-trimester pregnancy with a progressive increase in oxygen requirement. Remdesivir may prove beneficial in reducing the inflammatory response and controlling the direct viral damage due to severe COVID-19 pneumonia resulting in favorable maternal and fetal outcomes.

    © 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved